Serpin Pharma Receives FDA Clearance of IND Application for SP16 for Chemotherapy-Induced Peripheral Neuropathy
Serpin Pharma receives FDA IND approval for SP16, a novel therapy for chemotherapy-induced peripheral neuropathy. Phase 1b trial initiation planned MANASSAS, VA, UNITED STATES, April 15, 2026 /EINPresswire.com/ -- Serpin Pharma Inc., a clinical-stage …